493 related articles for article (PubMed ID: 18319601)
1. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.
Augustin M; Krüger K; Radtke MA; Schwippl I; Reich K
Dermatology; 2008; 216(4):366-72. PubMed ID: 18319601
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
Reich K; Krüger K; Mössner R; Augustin M
Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
[TBL] [Abstract][Full Text] [Related]
3. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
Schöffski O; Augustin M; Prinz J; Rauner K; Schubert E; Sohn S; Reich K
J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
[TBL] [Abstract][Full Text] [Related]
4. Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
Feldman SR; Gottlieb AB; Bala M; Wu Y; Eisenberg D; Guzzo C; Li S; Dooley LT; Menter A
Br J Dermatol; 2008 Sep; 159(3):704-10. PubMed ID: 18627375
[TBL] [Abstract][Full Text] [Related]
5. Quality of psoriasis care in Germany--results of the national study PsoHealth 2007.
Augustin M; Reich K; Reich C; Purwins S; Jeff Rustenbach S; Schäfer I; Radtke M
J Dtsch Dermatol Ges; 2008 Aug; 6(8):640-5. PubMed ID: 18801145
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial.
Flytström I; Stenberg B; Svensson A; Bergbrant IM
Br J Dermatol; 2008 Jan; 158(1):116-21. PubMed ID: 17986302
[TBL] [Abstract][Full Text] [Related]
7. The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab.
Reich K; Griffiths CE
Arch Dermatol Res; 2008 Nov; 300(10):537-44. PubMed ID: 18784934
[TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study.
Jacobi A; Kupke C; Behzad M; Hertl M
Int J Dermatol; 2013 Sep; 52(9):1081-7. PubMed ID: 23432542
[TBL] [Abstract][Full Text] [Related]
10. Suffering in psoriasis patients: its relation with illness severity and subjective well-being.
Reimus JL; Vingerhoets AJ; Soons PH; Korstanje MJ
Int J Dermatol; 2007 Oct; 46(10):1042-5. PubMed ID: 17910711
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
Fortune DG; Main CJ; O'Sullivan TM; Griffiths CE
Br J Dermatol; 1997 Nov; 137(5):755-60. PubMed ID: 9415236
[TBL] [Abstract][Full Text] [Related]
12. The effect of treatment on quality of life in psoriasis patients.
Prins M; Krabbe PF; Swinkels QO; de Boo T; van de Kerkhof PC; van der Valk PG
Acta Derm Venereol; 2005; 85(4):304-10. PubMed ID: 16191850
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of psoriasis therapy with etanercept in Germany.
Heinen-Kammerer T; Daniel D; Stratmann L; Rychlik R; Boehncke WH
J Dtsch Dermatol Ges; 2007 Sep; 5(9):762-8. PubMed ID: 17760896
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitiligo on self-reported health-related quality of life.
Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
[TBL] [Abstract][Full Text] [Related]
15. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
[TBL] [Abstract][Full Text] [Related]
16. A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe.
Palota T; Szepietowski JC; Pec J; Arenberger P; Giurcaneanu C; Gyulai R; Miljkovic J; Pärna E; Mikazans I; Grusauskas N; Hodik M
Acta Dermatovenerol Croat; 2010; 18(3):151-61. PubMed ID: 20887696
[TBL] [Abstract][Full Text] [Related]
17. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.
Sampogna F; Chren MM; Melchi CF; Pasquini P; Tabolli S; Abeni D;
Br J Dermatol; 2006 Feb; 154(2):325-31. PubMed ID: 16433804
[TBL] [Abstract][Full Text] [Related]
18. Synchronous balneophototherapy is effective for the different clinical types of psoriasis.
Holló P; Gonzalez R; Kása M; Horváth A
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):578-81. PubMed ID: 16164712
[TBL] [Abstract][Full Text] [Related]
19. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
20. A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO).
Lambert J; Dowlatshahi EA; de la Brassinne M; Nijsten T
Eur J Dermatol; 2012; 22(2):231-7. PubMed ID: 22266338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
